OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
November 05, 2009
Lonza (Basel, Switzerland), the large contract manufacturer of small-molecule and biologic-based active pharmaceutical ingredients (APIs), announced last week a series of cost-cutting measures for the next 12 to 18 months.
November 02, 2009
Functionalized supramolecular catalysts and an enantioselective route to unnatural amino acids are some recent developments.
October 30, 2009
The House Energy and Commerce Committee has approved H.R. 2868, the "Chemical Facility Anti-Terrorism Act of 2009", a measure to modify and codify existing requirements of the Chemical Facility Anti-Terrorism Standards (CFATS) programme.
October 29, 2009
The House Energy and Commerce Committee approved H.R. 2868, the "Chemical Facility Anti-Terrorism Act of 2009," a measure to modify and codify existing requirements of the Chemical Facility Anti-Terrorism Standards (CFATS) program.
October 23, 2009
Following the completion of its $68-billion acquisition of Wyeth, Pfizer has begun operations at the new combined company.
October 22, 2009
Following the completion of its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) began joint operations of the combined company last week.